Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Approaches to sample size calculation for clinical trials in rare diseases

Tools
- Tools
+ Tools

Miller, Frank, Zohar, Sarah, Stallard, Nigel, Madan, Jason, Posch, Martin, Hee, Siew Wan, Pearce , Michael, Vågerö, Mårten and Day, Simon (2018) Approaches to sample size calculation for clinical trials in rare diseases. Pharmaceutical Statistics, 17 (3). pp. 214-230. doi:10.1002/pst.1848

[img]
Preview
PDF
WRAP-approaches-sample-size-calculation-clinical-trials-diseases-Stallard-2017.pdf - Accepted Version - Requires a PDF viewer.

Download (1607Kb) | Preview
Official URL: http://doi.org/10.1002/pst.1848

Request Changes to record.

Abstract

We discuss 3 alternative approaches to sample size calculation: traditional sample size calculation based on power to show a statistically significant effect, sample size calculation based on assurance, and sample size based on a decision-theoretic approach. These approaches are compared head-to-head for clinical trial situations in rare diseases. Specifically, we consider 3 case studies of rare diseases (Lyell disease, adult-onset Still disease, and cystic fibrosis) with the aim to plan the sample size for an upcoming clinical trial. We outline in detail the reasonable choice of parameters for these approaches for each of the 3 case studies and calculate sample sizes. We stress that the influence of the input parameters needs to be investigated in all approaches and recommend investigating different sample size approaches before deciding finally on the trial size. Highly influencing for the sample size are choice of treatment effect parameter in all approaches and the parameter for the additional cost of the new treatment in the decision-theoretic approach. These should therefore be discussed extensively.

Item Type: Journal Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Clinical trials -- Mathematical models, Rare diseases, Toxic epidermal necrolysis, Cystic fibrosis
Journal or Publication Title: Pharmaceutical Statistics
Publisher: John Wiley & Sons Ltd.
ISSN: 1539-1604
Official Date: 1 May 2018
Dates:
DateEvent
1 May 2018Published
10 January 2018Available
8 December 2017Accepted
Volume: 17
Number: 3
Page Range: pp. 214-230
DOI: 10.1002/pst.1848
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
2013602144Seventh Framework Programmehttp://dx.doi.org/10.13039/100011102
Related URLs:
  • Publisher

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us